Evidence map›Paper›PMID 28595995›Full record

ArticleThe Journal of investigative dermatology2017

miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis.

Helen Hermann, Toomas Runnel, Alar Aab, Hansjörg Baurecht, Elke Rodriguez, Nathaniel Magilnick, Egon Urgard, Liisi Šahmatova, Ele Prans, Julia Maslovskaja and 23 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 4 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 4 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. MicroRNAs in atopic dermatitis: A systematic review.Journal of cellular and molecular medicine · 2020
    Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. The effect of plasma exosomal microRNA- 148a- 3p on the CD4Archives of dermatological research · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 9 institutions in 5 countries.

Helen HermannInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Toomas RunnelInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia; Institute of Molecular and Cellular Biology, University of Tartu, Tartu, Estonia.
Alar AabInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Hansjörg BaurechtDepartment of Dermatology, University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany.
Elke RodriguezDepartment of Dermatology, University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany.
Nathaniel MagilnickDepartment of Molecular and Cellular Biology, Beckman Research Institute of City of Hope National Medical Center, Duarte, California, USA.
Egon UrgardInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Liisi ŠahmatovaDepartment of Dermatology and Venereology, University of Tartu, Tartu, Estonia; Dermatology Clinic, Tartu University Hospital, Tartu, Estonia.
Ele PransInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia; Department of Dermatology and Venereology, University of Tartu, Tartu, Estonia.
Julia MaslovskajaInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Kristi AbramDermatology Clinic, Tartu University Hospital, Tartu, Estonia.
Maire KarelsonDermatology Clinic, Tartu University Hospital, Tartu, Estonia.
Bret KaldveeDepartment of Dermatology and Venereology, University of Tartu, Tartu, Estonia; Dermatology Clinic, Tartu University Hospital, Tartu, Estonia.
Paula ReemannInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Uku HaljasorgInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Beate RückertSwiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Davos, Switzerland.
Paulina WawrzyniakSwiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Davos, Switzerland.
Michael WeichenthalDepartment of Dermatology, University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany.
Ulrich MrowietzDepartment of Dermatology, University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany.
Andre FrankeInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Christian GiegerInstitute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
Jonathan BarkerDivision of Genetics and Molecular Medicine, King's College London, London, UK; St John's Institute of Dermatology, King's College London, London, UK.
Richard TrembathBarts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Lam C TsoiDepartment of Dermatology, University of Michigan, Ann Arbor, Michigan, USA; Ann Arbor Veterans Affairs Hospital, Ann Arbor, Michigan, USA.
James T ElderDepartment of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan, USA.
Eric R TkaczykInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Kai KisandInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Pärt PetersonInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Külli KingoDepartment of Dermatology and Venereology, University of Tartu, Tartu, Estonia; Dermatology Clinic, Tartu University Hospital, Tartu, Estonia.
Mark BoldinDepartment of Molecular and Cellular Biology, Beckman Research Institute of City of Hope National Medical Center, Duarte, California, USA.
Stephan WeidingerDepartment of Dermatology, University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany.
Cezmi A AkdisSwiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Davos, Switzerland.
Ana RebaneInstitute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia. Electronic address: ana.rebane@ut.ee.
University of Tartu · EEChristian-Albrechts-Universität zu Kiel · DETartu University Hospital · EEUniversity of Zurich · CHCity Of Hope National Medical Center · USUniversity of Michigan · USHelmholtz Zentrum München · DEKing's College London · GBQueen Mary University of London · GB

Funding

Vanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9M
Paul Calabresi Clinical Oncology AwardK12CA088084 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI David S. Hong, Scott Kopetz · 2000 to 2026
$14.0M
Linkage analysis of familial psoriasis(Supplement)R01AR042742 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELDER, JAMES TILFORD · 1994 to 2021
$10.1M
Genetic and Genomic Dissection of Psoriatic ArthritisR01AR063611 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELDER, JAMES TILFORD, GLADMAN, DAFNA D · 2012 to 2023
$6.2M
Identification of Psoriatic Arthritis Genes in the MHCR01AR050511 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELDER, JAMES TILFORD · 2004 to 2013
$4.2M
Combined Analysis of Gene Expression and DNA Variation in PsoriasisR01AR054966 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELDER, JAMES TILFORD · 2007 to 2011
$3.2M
Functional Genomics of PsoriasisR01AR065183 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELDER, JAMES TILFORD · 2013 to 2016
$1.7M
NCI NIH HHS K12 CA088084NCI NIH HHS K12 CA090625NIAMS NIH HHS R01 AR042742NIAMS NIH HHS R01 AR050511NIAMS NIH HHS R01 AR054966NIAMS NIH HHS R01 AR063611NIAMS NIH HHS R01 AR065183Wellcome Trust
6 · The paper itself

Abstract

miR-146a inhibits inflammatory responses in human keratinocytes and in different mouse models of skin inflammation. Little is known about the role of miR-146b in the skin. In this study, we confirmed the increased expression of miR-146a and miR-146b (miR-146a/b) in the lesional skin of patients with psoriasis. The expression of miR-146a was approximately twofold higher than that of miR-146b in healthy human skin, and it was more strongly induced by stimulation of proinflammatory cytokines in keratinocytes and fibroblasts. miR-146a/b target genes regulating inflammatory responses or proliferation were altered in the skin of patients with psoriasis, among which FERMT1 was verified as a direct target of miR-146a. In silico analysis of genome-wide data from >4,000 psoriasis cases and >8,000 controls confirmed a moderate association between psoriasis and genetic variants in the miR-146a encoding gene. Transfection of miR-146a/b suppressed and inhibition enhanced keratinocyte proliferation and the expression of psoriasis-related target genes. Enhanced expression of miR-146a/b-influenced genes was detected in cultured keratinocytes from miR-146a

Indexed as

Gene Expression RegulationAnimalsApoptosisCase-Control StudiesCell ProliferationCells, CulturedDermatitisDisease Models, AnimalHumansKeratinocytesMiceMice, Inbred C57BLMicroRNAsPsoriasisReal-Time Polymerase Chain ReactionMicroRNAsMirn146 microRNA, mouse

Identifiers

PMID28595995
PMCPMC5977389
OpenAlexW2622265102

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.